Valvular disease in 2010: evolution and revolution in risk stratification and therapy.
During 2010, several landmark studies, including the Partner trial,have made huge advances in the field of transcatheter aortic valve implantation. Other studies have made major contributions to the therapeutic management of young adult patients with severe aortic valve disease and of patients with asymptomatic severe mitral regurgitation.